Budesonide Foam for Ulcerative Colitis Patients Experiencing Inadequate Response to Biological Therapy

BACKGROUND: In recent years, a plethora of therapeutic agents for ulcerative colitis (UC), especially novel biologics (Bio), have become available. Although it is now possible to use biological drugs, there should be no need for frequently changing medications. To avoid first-pass metabolism in the...

詳細記述

保存先:
書誌詳細
出版年:Med Sci Monit
主要な著者: Shibuya, Tomoyoshi, Nomura, Kei, Okahara, Koki, Haga, Keiichi, Nomura, Osamu, Murakami, Takashi, Uchida, Shino, Kodani, Tomohiro, Ishikawa, Dai, Sakamoto, Naoto, Ogihara, Tatsuo, Osada, Taro, Nagahara, Akihito
フォーマット: Artigo
言語:Inglês
出版事項: International Scientific Literature, Inc. 2019
主題:
Clinical Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6939661/
https://ncbi.nlm.nih.gov/pubmed/31865359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.918562
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料